Galectin Therapeutics Inc.
(NASDAQ : GALT)

( )
GALT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
1.43%89.631.3%$877.94m
AMGNAmgen Inc.
0.40%191.891.2%$550.47m
GILDGilead Sciences, Inc.
0.50%64.920.9%$461.62m
BIIBBiogen Inc.
-29.23%226.881.3%$457.10m
ONCESpark Therapeutics, Inc.
-0.20%113.2711.2%$443.03m
REGNRegeneron Pharmaceuticals, Inc.
-0.72%402.592.6%$280.51m
ILMNIllumina, Inc.
1.24%319.213.5%$280.06m
VRTXVertex Pharmaceuticals Incorporated
1.43%182.561.9%$232.81m
SRPTSarepta Therapeutics, Inc.
2.27%126.6615.4%$211.90m
EXASExact Sciences Corporation
1.70%92.0225.3%$191.93m
ALXNAlexion Pharmaceuticals, Inc.
1.94%134.212.0%$186.57m
BPTHBio-Path Holdings, Inc.
-14.05%18.48190.1%$182.12m
AAgilent Technologies, Inc.
1.34%82.001.6%$143.35m
IONSIonis Pharmaceuticals, Inc.
0.36%80.508.3%$105.13m
BMRNBioMarin Pharmaceutical Inc.
0.91%90.784.3%$95.05m

Company Profile

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.